Adi Yugatama
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Adi Yugatama has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Adiba K Mawarni
Pharmacy Department, Universitas Sebelas Maret
1 shared publicationAlyanis Mufid Swm
Department of Pharmacy, Universitas Sebelas Maret, Jl. Ir. Sutami 36A, Surakarta, Indonesia, 57126
1 shared publication- Anas Muti'Ah Syahrul Azizah
Department of Pharmacy, Faculty of Mathematics and Natural Sciences, Universitas Sebelas Maret, Surakarta, 57126, Indonesia
1 shared publication Chien-Ming Hsieh
1 shared publicationDavid Sarono Putro
Department of Pharmacy, Mathematics and Natural Science Faculty, Universitas Sebelas Maret, Jalan Ir. Sutami 36 A Kentingan, Jebres, Surakarta 57126
1 shared publication- Dedik Sulistiawan
Universitas Ahmad Dahlan, Yogyakarta
1 shared publication
Latest Publications
- Open Access
- 5 November 2025
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 115
Design and development of dual drug-loaded liposomes encapsulating gentamicin and curcumin via microfluidic synthesis: A Box-Behnken experimental approach
- 5 November 2025
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 115
Open AccessDesign and development of dual drug-loaded liposomes encapsulating gentamicin and curcumin via microfluidic synthesis: A Box-Behnken experimental approach
- Open Access
- 2 October 2025
- Published by Etflin in Sciences of Pharmacy
- Vol. 4 (4) , 261-269
The Effect of Poloxamer 188 on the Solubility and Dissolution Behaviors of Piroxicam-PEG 4000 Solid Dispersions
Piroxicam (PRX), a non-steroidal anti-inflammatory drug (NSAID), is classified as a biopharmaceutical classification system class II (high permeability and low solubility), which limits its bioavailability. Enhancement of the dissolution rate is a key strategy to enhance the absorption. Solid dispersion systems, particularly when combined with amphiphilic multiple co-block polymers, offer a promising approach to address this challenge. This study aimed to investigate the effect of Poloxamer 188 (P188) and the solid dispersion technique on the solubility and dissolution rate of PRX. Polyethylene glycol (PEG) 4000-based solid dispersions containing PRX were prepared using varying concentrations of Poloxamer 188 surfactant through the fusion method. The solid dispersions were evaluated for saturated solubility in water for 24 hours. Selected formulations were further characterized using thermal analysis and vibrational spectroscopy. The optimized solid dispersion formulation was filled into capsules, and a dissolution assay was carried out to compare its performance with that of pure PRX capsules. The optimized formula, comprising 3% P188 and PEG4000, demonstrated a significant enhancement in saturation solubility parameters (p < 0.05), specifically the Cmax/S0 ratio. Additionally, dissolution testing showed a 22.22% increase in the dissolution rate of the PRX solid dispersion capsules compared to pure PRX capsules. In conclusion, P188-based solid dispersion containing PRX enhanced the solubility and dissolution rate, potentially improving therapeutic efficacy.
- 2 October 2025
- Published by Etflin in Sciences of Pharmacy
- Vol. 4 (4) , 261-269
Open AccessThe Effect of Poloxamer 188 on the Solubility and Dissolution Behaviors of Piroxicam-PEG 4000 Solid Dispersions
Piroxicam (PRX), a non-steroidal anti-inflammatory drug (NSAID), is classified as a biopharmaceutical classification system class II (high permeability and low solubility), which limits its bioavailability. Enhancement of the dissolution rate is a key strategy to enhance the absorption. Solid dispersion systems, particularly when combined with amphiphilic multiple co-block polymers, offer a promising approach to address this challenge. This study aimed to investigate the effect of Poloxamer 188 (P188) and the solid dispersion technique on the solubility and dissolution rate of PRX. Polyethylene glycol (PEG) 4000-based solid dispersions containing PRX were prepared using varying concentrations of Poloxamer 188 surfactant through the fusion method. The solid dispersions were evaluated for saturated solubility in water for 24 hours. Selected formulations were further characterized using thermal analysis and vibrational spectroscopy. The optimized solid dispersion formulation was filled into capsules, and a dissolution assay was carried out to compare its performance with that of pure PRX capsules. The optimized formula, comprising 3% P188 and PEG4000, demonstrated a significant enhancement in saturation solubility parameters (p < 0.05), specifically the Cmax/S0 ratio. Additionally, dissolution testing showed a 22.22% increase in the dissolution rate of the PRX solid dispersion capsules compared to pure PRX capsules. In conclusion, P188-based solid dispersion containing PRX enhanced the solubility and dissolution rate, potentially improving therapeutic efficacy.
- 7 September 2025
- Published by Elsevier in Research in Social and Administrative Pharmacy
- Vol. 22 (1) , 152-161
Development and psychometric evaluation of knowledge, attitude, and behavior questionnaire on fall risk–increasing drugs (KABQ-FRID)
- 7 September 2025
- Published by Elsevier in Research in Social and Administrative Pharmacy
- Vol. 22 (1) , 152-161
Development and psychometric evaluation of knowledge, attitude, and behavior questionnaire on fall risk–increasing drugs (KABQ-FRID)
- Open Access
- 28 May 2024
- Published by Universitas Sebelas Maret in JPSCR: Journal of Pharmaceutical Science and Clinical Research
- Vol. 9 (1) , 181-193
The Influence of Release Modifier Differences in Formulations on the Pharmacokinetic Profile of Ketoprofen in Rats: A Scoping Review
The pharmacokinetic profile of drugs can be changed by genetic, environmental, and physiological variables such as age, sex, pregnancy, and different preparations and formulations. Ketoprofen is widely used in many different preparations and formulations. The various formulations can made by adding solubilizing and extending release agents. This study aimed to determine the influence of formulation differences on the pharmacokinetic profile of ketoprofen in rats. This research was a Literature Review. Articles were retrieved from the ScienceDirect and PubMed databases from 2011 to 2020. The inclusion criteria were the research article, the presence of ketoprofen was formulated with the addition of a solubilizing or extended-release agent, given orally and available in open access. The study resulted in differences in formulation, notably the addition of various dissolving agents or extended-release agents, which caused changes in the pharmacokinetic profile of ketoprofen. The highest increase in the pharmacokinetic parameters Cmax and AUC of ketoprofen was observed with poloxamer-188 as a release modifier agent. Therefore, the use of release modifier agents could have a significant effect on the drug's pharmacokinetic profile.
- 28 May 2024
- Published by Universitas Sebelas Maret in JPSCR: Journal of Pharmaceutical Science and Clinical Research
- Vol. 9 (1) , 181-193
Open AccessThe Influence of Release Modifier Differences in Formulations on the Pharmacokinetic Profile of Ketoprofen in Rats: A Scoping Review
The pharmacokinetic profile of drugs can be changed by genetic, environmental, and physiological variables such as age, sex, pregnancy, and different preparations and formulations. Ketoprofen is widely used in many different preparations and formulations. The various formulations can made by adding solubilizing and extending release agents. This study aimed to determine the influence of formulation differences on the pharmacokinetic profile of ketoprofen in rats. This research was a Literature Review. Articles were retrieved from the ScienceDirect and PubMed databases from 2011 to 2020. The inclusion criteria were the research article, the presence of ketoprofen was formulated with the addition of a solubilizing or extended-release agent, given orally and available in open access. The study resulted in differences in formulation, notably the addition of various dissolving agents or extended-release agents, which caused changes in the pharmacokinetic profile of ketoprofen. The highest increase in the pharmacokinetic parameters Cmax and AUC of ketoprofen was observed with poloxamer-188 as a release modifier agent. Therefore, the use of release modifier agents could have a significant effect on the drug's pharmacokinetic profile.
- Open Access
- 2 February 2022
- Published by Universitas Padjadjaran in Indonesian Journal of Pharmaceutical Science and Technology
- Vol. 9 (1) , 31-44
Volume Variation of Sweet Orange (Citrus sinensis) Juice and Peel Extract Toward the Characteristic and Antibacterial Activity of Nanosilver
Biosynthesis of nanosilver by using sweet orange (C. sinensis) as a bioreductor has shown nanosized results. In this research, the effect of volume variation of sweet orange juice and peel extract combination toward the characteristics and antibacterial activity of synthesized nanosilver will be studied. Solution of AgNO3 1 mM was mixed with a combination of sweet orange juice – peel extract with ratios (v/v), 3:0; 1.5:1.5; 1:2; 0.5:2.5 and 0:3 at 60˚C for 45 minutes. The color change of the mixed solution indicated the formation of nanosilver and confirmed by using UV/Vis spectrophotometer and TEM analysis. The results show that the addition of sweet orange juice in combination accelerated the color change of the mixed solution. The characterization of nanosilver with UV/Vis spectrophotometer confirmed SPR peak at 438-459 nm. The stability test showed that nanosilver reduced with sweet orange juice-peel extract 0,5:2,5 (v/v) was stable and had inhibition diameter tested by the diffusion method against S.aureus (19.50 mm) and S.epidermidis (18.09 mm), indicates a moderate inhibition. Its TEM analysis confirmed the particle's size of about 30-56 nm with spherical form.Keywords: nanosilver, biosynthesis, Citrus sinensis, characteristic, antibacterial activity
- 2 February 2022
- Published by Universitas Padjadjaran in Indonesian Journal of Pharmaceutical Science and Technology
- Vol. 9 (1) , 31-44
Open AccessVolume Variation of Sweet Orange (Citrus sinensis) Juice and Peel Extract Toward the Characteristic and Antibacterial Activity of Nanosilver
Biosynthesis of nanosilver by using sweet orange (C. sinensis) as a bioreductor has shown nanosized results. In this research, the effect of volume variation of sweet orange juice and peel extract combination toward the characteristics and antibacterial activity of synthesized nanosilver will be studied. Solution of AgNO3 1 mM was mixed with a combination of sweet orange juice – peel extract with ratios (v/v), 3:0; 1.5:1.5; 1:2; 0.5:2.5 and 0:3 at 60˚C for 45 minutes. The color change of the mixed solution indicated the formation of nanosilver and confirmed by using UV/Vis spectrophotometer and TEM analysis. The results show that the addition of sweet orange juice in combination accelerated the color change of the mixed solution. The characterization of nanosilver with UV/Vis spectrophotometer confirmed SPR peak at 438-459 nm. The stability test showed that nanosilver reduced with sweet orange juice-peel extract 0,5:2,5 (v/v) was stable and had inhibition diameter tested by the diffusion method against S.aureus (19.50 mm) and S.epidermidis (18.09 mm), indicates a moderate inhibition. Its TEM analysis confirmed the particle's size of about 30-56 nm with spherical form.Keywords: nanosilver, biosynthesis, Citrus sinensis, characteristic, antibacterial activity
- Open Access
- 1 May 2021
- Published by IOP Publishing in Journal of Physics: Conference Series
- Vol. 1912 (1) , 012047
A systematic literature review (SLR): evaluation pharmacokinetic profile of drug combined p-glycoprotein (p-gp) alkaloid inhibitor in white rats (rattus norvegicus)
P-glycoprotein (P-gp) is a protein transporter as an active efflux pump of many xenobiotics. P-gp plays an important role in the pharmacokinetic process that it will affect the bioavailability of the drug. Secondary metabolites of alkaloids are known to be P-gp inhibitors which can modulate P-gp expression so it will increase the bioavailability of various drugs. The aim of this study was to determine the effect of alkaloid administration as a P-gp inhibitor on the pharmacokinetic profile of drugs in white rats (Rattus norvegicus). This research is a Systematic Literature Review (SLR). Articles were retrieved from the Science Direct and Pubmed databases from 2000 to 2020 with the inclusion criteria are P-gp substrate used as a synthetic drug also has a pharmacokinetic profile measurement and exclusion criteria are articles in English and there were no duplication of articles. SLR research results show that secondary metabolites of alkaloids can significantly change the pharmacokinetic parameters of P-gp substrate such as the area under curve (AUC), peak plasma concentrations (Cmax) and time to reach Cmax (Tmax), clearance (Cl), distribution volume (Vd) and half-life (T1/2) in white rats (Rattus norvegicus). Therefore, it shows that alkaloids can act as P-gp inhibitors.
- 1 May 2021
- Published by IOP Publishing in Journal of Physics: Conference Series
- Vol. 1912 (1) , 012047
Open AccessA systematic literature review (SLR): evaluation pharmacokinetic profile of drug combined p-glycoprotein (p-gp) alkaloid inhibitor in white rats (rattus norvegicus)
P-glycoprotein (P-gp) is a protein transporter as an active efflux pump of many xenobiotics. P-gp plays an important role in the pharmacokinetic process that it will affect the bioavailability of the drug. Secondary metabolites of alkaloids are known to be P-gp inhibitors which can modulate P-gp expression so it will increase the bioavailability of various drugs. The aim of this study was to determine the effect of alkaloid administration as a P-gp inhibitor on the pharmacokinetic profile of drugs in white rats (Rattus norvegicus). This research is a Systematic Literature Review (SLR). Articles were retrieved from the Science Direct and Pubmed databases from 2000 to 2020 with the inclusion criteria are P-gp substrate used as a synthetic drug also has a pharmacokinetic profile measurement and exclusion criteria are articles in English and there were no duplication of articles. SLR research results show that secondary metabolites of alkaloids can significantly change the pharmacokinetic parameters of P-gp substrate such as the area under curve (AUC), peak plasma concentrations (Cmax) and time to reach Cmax (Tmax), clearance (Cl), distribution volume (Vd) and half-life (T1/2) in white rats (Rattus norvegicus). Therefore, it shows that alkaloids can act as P-gp inhibitors.
- Open Access
- 8 April 2019
- Published by Universitas Sebelas Maret in JPSCR: Journal of Pharmaceutical Science and Clinical Research
- Vol. 4 (1) , 52-59
Analisis Kandungan Timbal dalam Beberapa Sediaan Kosmetik yang Beredar di Kota Surakarta
Penggunaan sediaan kosmetik di Indonesia semakin meningkat. Beberapa sediaan kosmetika yang sering digunakan oleh masyarakat adalah eye-liner pencil, bedak, dan lipstik. Sediaan kosmetik dapat dikatakan aman apabila memenuhi jumlah maksimum kadar timbal yang sesuai dengan persyaratan yang ada. Penelitian ini bertujuan untuk mengetahui kadar logam timbal dalam sediaan kosmestik eye-liner pencil, bedak, dan lipstik yang beredar di Kota Surakarta. Pengambilan sampel dilakukan di berbagai tempat di kota Surakarta dengan metode purposive sampling. Preparasi sampel dilakukan dengan metode destruksi basah dengan campuran larutan asam HNO3 dan HCl (1:3). Sampel dianalisis menggunakan spektrofotometer serapan atom (SSA) dan diperoleh nilai absorbansinya dan dimasukkan ke dalam kurva kalibrasi sehingga dapat dihitung kadar timbal dalam sampel. Hasil analisis diperoleh bahwa kadar timbal terbesar terdapat pada sediaan lipstik yaitu sebesar 23,1683 ± 0,1225 mg/kg dan kadar timbal terendah terdapat pada sediaan bedak yaitu sebesar 0,6001 ± 0,0092 mg/kg. Semua sediaan eye-liner pencil, bedak, dan lipstik yang beredar di Kota Surakarta telah memenuhi persyaratan batas maksimum kandungan timbal yang dipersyaratkan oleh BPOM, kecuali dua sampel lipstik yang tidak teregistrasi BPOM.
- 8 April 2019
- Published by Universitas Sebelas Maret in JPSCR: Journal of Pharmaceutical Science and Clinical Research
- Vol. 4 (1) , 52-59
Open AccessAnalisis Kandungan Timbal dalam Beberapa Sediaan Kosmetik yang Beredar di Kota Surakarta
Penggunaan sediaan kosmetik di Indonesia semakin meningkat. Beberapa sediaan kosmetika yang sering digunakan oleh masyarakat adalah eye-liner pencil, bedak, dan lipstik. Sediaan kosmetik dapat dikatakan aman apabila memenuhi jumlah maksimum kadar timbal yang sesuai dengan persyaratan yang ada. Penelitian ini bertujuan untuk mengetahui kadar logam timbal dalam sediaan kosmestik eye-liner pencil, bedak, dan lipstik yang beredar di Kota Surakarta. Pengambilan sampel dilakukan di berbagai tempat di kota Surakarta dengan metode purposive sampling. Preparasi sampel dilakukan dengan metode destruksi basah dengan campuran larutan asam HNO3 dan HCl (1:3). Sampel dianalisis menggunakan spektrofotometer serapan atom (SSA) dan diperoleh nilai absorbansinya dan dimasukkan ke dalam kurva kalibrasi sehingga dapat dihitung kadar timbal dalam sampel. Hasil analisis diperoleh bahwa kadar timbal terbesar terdapat pada sediaan lipstik yaitu sebesar 23,1683 ± 0,1225 mg/kg dan kadar timbal terendah terdapat pada sediaan bedak yaitu sebesar 0,6001 ± 0,0092 mg/kg. Semua sediaan eye-liner pencil, bedak, dan lipstik yang beredar di Kota Surakarta telah memenuhi persyaratan batas maksimum kandungan timbal yang dipersyaratkan oleh BPOM, kecuali dua sampel lipstik yang tidak teregistrasi BPOM.